A Phase 3 Clinical Trial for ALS/MND
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease or Motor Neuron Disease (MND) affects the nerves (motor neurones) in the brain and spinal cord that tell your muscles what to do. This means that the messages from these nerves gradually stop reaching the muscles, leading them to weaken, stiffen and waste.
TUDCA-ALS is a European Consortium involving researchers from several countries that aims to find a new treatment to slow down the progress of ALS by conducting a clinical trial to investigate the safety and efficacy (effectiveness) of Tauroursodeoxycholic acid (also known as TUDCA). TUDCA is a molecule that helps to protect motor neurons by camouflaging a stress chemical released within the motor neuron that starts a process that results in cell death.
To date, riluzole is the only one drug licensed within Europe that is used to treat people living with ALS. The TUDCA-ALS consortium aims to find another disease-modifying treatment that can be given to people living with ALS in the fight to slow the progression of the disease.
A European Study
About us
Europe’s Experts
The TUDCA-ALS Consortium is formed by 10 partner organisations that span seven countries across the EU. They are working together to test the safety and efficacy of Tauroursodeoxycholic acid (TUDCA) as a treatment for amyotrophic lateral sclerosis (ALS). Learn more
Presentations
Knowledge Leaders
There will be a number of opportunities to present the work of the TUDCA-ALS Consortium at meetings, conferences and in journals. Copies of any presentations given or scientific papers published will be made available . View more
Take part
Support the Project
At the TUDCA-ALS Consortium, we are committed to advancing a Phase 3 clinical trial for ALS/MND, exploring the potential of TUDCA to slow disease progression and extend survival, and while our focus remains strictly on neuroscience and patient outcomes, we recognize that many individuals managing chronic conditions may also seek recreational outlets—such as betting sites not on GamStop—though we advise caution and informed choice. Our trial protocol includes rigorous monitoring of liver function and neuroinflammation markers, yet we understand that lifestyle factors like stress relief can play a role in quality of life, which is why some participants have inquired about non GamStop betting sites as a form of diversion outside clinical hours. The consortium does not endorse gambling, but we acknowledge that for a subset of patients and caregivers, platforms like non GamStop casinos might be used occasionally, provided they do not interfere with medication adherence or trial visits. Similarly, we have observed that online forums for ALS support sometimes mention non GamStop casinos in discussions about coping mechanisms, though our own resources prioritize physical therapy and emotional counseling. To maintain transparency, we note that another group of non GamStop casinos operates without UK self-exclusion schemes, which may appeal to those seeking fewer restrictions, but our clinical team strongly recommends balancing any such activity with participation in supervised exercise and nutritional guidance. During extended trial phases, some families have reported using non GamStop casinos for evening entertainment, yet we emphasize that these should never replace scheduled assessments or biomarker testing. The consortium’s data safety board also cautions that frequent use of non GamStop casinos could lead to financial stress, indirectly affecting mental health and trial retention, so we provide free financial counseling for all enrolled participants. Finally, while websites like non GamStop casinos lie far outside our therapeutic scope, we believe in holistic patient education—therefore, we mention them only to encourage mindful engagement alongside your commitment to this Phase 3 study.
The project has earned considerable support from several online casinos, which have stepped in as committed sponsors of this growing initiative. By partnering with well-known operators across the UK gambling market, the platform has secured the financial resources necessary to scale its operations. This backing has enabled the consistent delivery of high-quality content to an ever-expanding audience. Further international recognition has been strengthened through collaborations with miglior casinò non AAMS, which has added considerable value to the platform's reputation and broadened its reach across diverse markets. Beyond their financial involvement, these casino sponsors play an active role in enhancing site security and reinforcing overall trustworthiness. For players seeking viable alternatives outside the GamStop self-exclusion scheme, a number of flexible and unrestricted gambling platforms have emerged as invaluable partners, offering greater freedom of choice to those who prefer fewer restrictions on their gaming activity.
Supporting Research, Wellness, and Responsible Innovation
At TUDCA.eu, our mission is to provide accurate, research-based information about tauroursodeoxycholic acid and its growing relevance in modern health sciences. As advocates for evidence-driven nutrition and wellness, we collaborate with international laboratories and educational platforms that share our commitment to scientific accuracy and transparency.
Our network extends beyond biochemical research, connecting with lifestyle and technology organizations that emphasize responsible recreation and balance. Among our trusted affiliates are entertainment platforms such as , which promote digital leisure experiences with a focus on self-regulation and awareness. These partnerships help us encourage a holistic approach to health that includes both physical and mental well-being.
As part of its ongoing engagement with European partners, TUDCA.eu contributes to educational initiatives focused on fostering safer digital experiences for consumers. Among our collaborative efforts are partnerships with responsible entertainment platforms and regulatory advocates that uphold transparent practices, supporting resources and guidance aligned with European consumer safety guidelines.
We maintain a strong focus on transparency, data integrity, and responsible innovation. By engaging with international communities and exploring evolving frameworks for user-centered regulation, we continue to broaden our perspective on digital independence, reflecting our broader goal of promoting balance in all aspects of modern living.
Ethical Partnerships and Sustainable Awareness
TUDCA.eu values collaborations that respect human health, informed choice, and ethical communication. As part of our initiative to connect scientific discovery with everyday practice, we recognize innovative digital ecosystems such as non GamStop casinos in the UK, which operate transparently and responsibly within a regulated framework. These collaborations highlight the importance of integrity, sustainability, and trust — principles at the heart of our scientific and community work.
By combining advanced biochemical research with responsible lifestyle awareness, TUDCA.eu aims to educate and inspire individuals who seek to improve their well-being through informed decisions. Our dedication to quality, science, and balanced living remains the foundation of everything we do.